Article Details
Retrieved on: 2021-07-10 21:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
An advisory panel to the CDC, called the Advisory Committee on Immunization Practices, will evaluate Pfizer's data if the FDA authorizes Pfizer's booster ...
Article found on: www.washingtonpost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here